JP5243552B2 - 磁気アシスト治療薬送達の方法とシステム - Google Patents
磁気アシスト治療薬送達の方法とシステム Download PDFInfo
- Publication number
- JP5243552B2 JP5243552B2 JP2010539863A JP2010539863A JP5243552B2 JP 5243552 B2 JP5243552 B2 JP 5243552B2 JP 2010539863 A JP2010539863 A JP 2010539863A JP 2010539863 A JP2010539863 A JP 2010539863A JP 5243552 B2 JP5243552 B2 JP 5243552B2
- Authority
- JP
- Japan
- Prior art keywords
- magnetic field
- magnetic
- carrier surface
- carrier
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001225 therapeutic effect Effects 0.000 title description 8
- 238000002716 delivery method Methods 0.000 title 1
- 230000005291 magnetic effect Effects 0.000 claims description 189
- 239000006249 magnetic particle Substances 0.000 claims description 45
- 239000003814 drug Substances 0.000 claims description 32
- 229940124597 therapeutic agent Drugs 0.000 claims description 31
- 239000000696 magnetic material Substances 0.000 claims description 17
- 230000003068 static effect Effects 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 description 17
- 239000000463 material Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 229910000859 α-Fe Inorganic materials 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229910000938 samarium–cobalt magnet Inorganic materials 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910052692 Dysprosium Inorganic materials 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- -1 biologics Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- KPLQYGBQNPPQGA-UHFFFAOYSA-N cobalt samarium Chemical compound [Co].[Sm] KPLQYGBQNPPQGA-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Magnetic Treatment Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US842307P | 2007-12-20 | 2007-12-20 | |
| US61/008,423 | 2007-12-20 | ||
| PCT/US2008/087628 WO2009086071A2 (en) | 2007-12-20 | 2008-12-19 | Systems and methods for magnetic-assisted therapeutic agent delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011507630A JP2011507630A (ja) | 2011-03-10 |
| JP2011507630A5 JP2011507630A5 (enExample) | 2012-02-09 |
| JP5243552B2 true JP5243552B2 (ja) | 2013-07-24 |
Family
ID=40825031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539863A Active JP5243552B2 (ja) | 2007-12-20 | 2008-12-19 | 磁気アシスト治療薬送達の方法とシステム |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8544474B2 (enExample) |
| EP (1) | EP2224994B1 (enExample) |
| JP (1) | JP5243552B2 (enExample) |
| WO (1) | WO2009086071A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8316862B2 (en) * | 2009-02-25 | 2012-11-27 | University Of Maryland | Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
| US11890226B2 (en) | 2009-02-25 | 2024-02-06 | University Of Maryland, College Park | Device and methods for directing agents into an eye |
| KR101814216B1 (ko) * | 2009-10-23 | 2018-01-02 | 가꼬우호진 시바우라 고교 다이가꾸 | 자기 유도 시스템과 그 동작 방법 |
| US10136986B2 (en) | 2014-05-09 | 2018-11-27 | Mayo Foundation For Medical Education And Research | Devices and methods for endothelialization of magnetic vascular grafts |
| EP3166648B1 (en) * | 2014-07-08 | 2025-02-19 | University of Maryland, Baltimore | Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations |
| CN107106252B (zh) * | 2014-10-30 | 2021-04-30 | 奥托磁有限责任公司 | 通过添加具有不同磁化和导磁率的材料突出件来磁性注射治疗试剂 |
| KR102105910B1 (ko) * | 2017-06-23 | 2020-04-29 | 전남대학교 산학협력단 | 자석 배열을 이용한 치료제 표적화 및 고정 의료장치 |
| US20220226073A1 (en) * | 2019-05-30 | 2022-07-21 | Indian Institute Of Science | Controlling motion of magnetically-driven microscopic particles |
| EP4262959A1 (en) * | 2020-12-15 | 2023-10-25 | Otomagnetics, Inc. | Medical cart for magnetic treatment of middle ear conditions |
| US11610731B2 (en) | 2021-03-09 | 2023-03-21 | Hirofusa Otsubo | Apparatus for assembling a non-directional free electron generating repelling magnet combination |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5125888A (en) * | 1990-01-10 | 1992-06-30 | University Of Virginia Alumni Patents Foundation | Magnetic stereotactic system for treatment delivery |
| US5921244A (en) * | 1997-06-11 | 1999-07-13 | Light Sciences Limited Partnership | Internal magnetic device to enhance drug therapy |
| US6203487B1 (en) | 1997-12-31 | 2001-03-20 | Thomas Jefferson University | Use of magnetic particles in the focal delivery of cells |
| EP1045714A1 (en) | 1998-01-08 | 2000-10-25 | Sontra Medical, L.P. | Sonophoretic enhanced transdermal transport |
| US6148823A (en) * | 1999-03-17 | 2000-11-21 | Stereotaxis, Inc. | Method of and system for controlling magnetic elements in the body using a gapped toroid magnet |
| US6544163B2 (en) * | 2000-12-28 | 2003-04-08 | Scimed Life Systems, Inc. | Apparatus and method for controlling a magnetically controllable embolic in the embolization of an aneurysm |
| US20020133225A1 (en) * | 2001-03-13 | 2002-09-19 | Gordon Lucas S. | Methods and apparatuses for delivering a medical agent to a medical implant |
| FI1383572T4 (fi) | 2001-05-04 | 2023-10-09 | Laitteisto ja menetelmät transkraniaalisen magneettistimulaation tuottamiseksi | |
| JP2002345968A (ja) * | 2001-05-29 | 2002-12-03 | Rikogaku Shinkokai | 薬剤の磁気輸送カテーテル |
| US7951061B2 (en) * | 2001-07-25 | 2011-05-31 | Allan Foreman | Devices for targeted delivery of thermotherapy, and methods related thereto |
| US7218962B2 (en) | 2002-03-29 | 2007-05-15 | Boston Scientific Scimed, Inc. | Magnetically enhanced injection catheter |
| US7189198B2 (en) | 2002-07-03 | 2007-03-13 | Stereotaxis, Inc. | Magnetically guidable carriers and methods for the targeted magnetic delivery of substances in the body |
| US6776165B2 (en) * | 2002-09-12 | 2004-08-17 | The Regents Of The University Of California | Magnetic navigation system for diagnosis, biopsy and drug delivery vehicles |
| US20060041182A1 (en) | 2003-04-16 | 2006-02-23 | Forbes Zachary G | Magnetically-controllable delivery system for therapeutic agents |
| US8001977B2 (en) * | 2005-04-08 | 2011-08-23 | Nanobiomagnetics, Inc. | Device for moving magnetic nanoparticles through tissue |
| US7723311B2 (en) | 2003-06-18 | 2010-05-25 | Nanobiomagnetics, Inc. | Delivery of bioactive substances to target cells |
| CN101173250B (zh) | 2003-06-30 | 2011-01-26 | 卫材R&D管理有限公司 | 磁性细胞及其使用方法 |
| AU2004272081A1 (en) | 2003-09-12 | 2005-03-24 | Bankruptcy Estate Of Ferx, Inc. | Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| US8465453B2 (en) | 2003-12-03 | 2013-06-18 | Mayo Foundation For Medical Education And Research | Kits, apparatus and methods for magnetically coating medical devices with living cells |
| US20070196281A1 (en) | 2003-12-31 | 2007-08-23 | Sungho Jin | Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article |
| DE112005002270T5 (de) * | 2004-09-28 | 2007-08-30 | Osaka University | Dreidimensionales Führungssystem und Verfahren, und Arznei-Zuführungssystem |
| EP1674128A1 (en) * | 2004-12-22 | 2006-06-28 | Steinbeis-Transferzentrum für Herz-Kreislaufforschung | Magnetic pole matrices useful for tissue engineering and treatment of disease |
| US20080294232A1 (en) * | 2007-05-22 | 2008-11-27 | Viswanathan Raju R | Magnetic cell delivery |
-
2008
- 2008-12-19 JP JP2010539863A patent/JP5243552B2/ja active Active
- 2008-12-19 US US12/809,197 patent/US8544474B2/en active Active
- 2008-12-19 WO PCT/US2008/087628 patent/WO2009086071A2/en not_active Ceased
- 2008-12-19 EP EP08868701.7A patent/EP2224994B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009086071A3 (en) | 2009-09-24 |
| EP2224994A4 (en) | 2012-05-02 |
| WO2009086071A2 (en) | 2009-07-09 |
| US8544474B2 (en) | 2013-10-01 |
| JP2011507630A (ja) | 2011-03-10 |
| US20110144411A1 (en) | 2011-06-16 |
| EP2224994B1 (en) | 2019-10-23 |
| EP2224994A2 (en) | 2010-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5243552B2 (ja) | 磁気アシスト治療薬送達の方法とシステム | |
| EP2401024B1 (en) | Devices, systems and methods for magnetic-assisted therapeutic agent delivery | |
| US20020133225A1 (en) | Methods and apparatuses for delivering a medical agent to a medical implant | |
| JP4913602B2 (ja) | 医用デバイスに生細胞を磁気的にコーティングするためのキット、装置、および方法 | |
| US8465453B2 (en) | Kits, apparatus and methods for magnetically coating medical devices with living cells | |
| JP2007512910A5 (enExample) | ||
| US20240407947A1 (en) | Devices and methods for directing agents into an eye | |
| US10463871B2 (en) | Apparatus and method for medical image-guided 3-D printing within a body | |
| CN107847429B (zh) | 使用纳米颗粒和外部场用来靶向或刺激细胞或生物体的方法 | |
| US10576295B2 (en) | Device and methods for directing agents to the middle ear and the inner ear | |
| US20080019917A1 (en) | Compositions Comprising Cells and Magnetic Materials for Targeted Delivery | |
| Fernández-Pacheco et al. | Magnetic nanoparticles for local drug delivery using magnetic implants | |
| US20250082952A1 (en) | Magnetically-assisted delivery into and through the skin | |
| EP3013287A1 (en) | Device and methods for directing agents into an eye | |
| Powar | Development status in the meadow of nanostructure magnetic drug delivery system and its promising applications | |
| KR102396312B1 (ko) | 체외에 위치한 자석 배열 장치와 병변 부위에 삽입된 자기 반응 임플란트를 이용한 골질환 치료제 표적화 장치 | |
| Garello et al. | Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents. Pharmaceutics 2022, 14, 1132 | |
| Mangual-Soto | Novel implant designs in magnetic drug targeting | |
| Ebner et al. | In Vitro Studies of Ferromagnetic Coils for Implant Assisted Magnetic Drug Targeting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111216 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111216 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130305 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130307 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130404 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160412 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5243552 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |